Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)
Clinical trial NCT01138397 · COMPLETED
Trial details
- NCT number
- NCT01138397
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2010-07-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.